Analyst Price Target is $53.29
▼ -22.85% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for TransMedics Group in the last 3 months. The average price target is $53.29, with a high forecast of $70.00 and a low forecast of $39.00. The average price target represents a -22.85% upside from the last price of $69.07.
Current Consensus is
The current consensus among 7 contributing investment analysts is to buy stock in TransMedics Group. This Buy consensus rating has held steady for over two years.